Term: hepatobiliary system morphology trait
Accession: VT:0002138
browse the term
Definition: Any measurable or observable characteristic related to the shape, structure, color or pattern of any of the tissues of the liver, gall bladder, or bile ducts.
Comment: pslim term
Synonyms: exact_synonym: hepatic system morphology trait
Q
Hpcl1
Hepatic cholesterol level QTL 1
IDA
3.3
RGD
PMID:9600105
RGD:629576
NCBI chr10:35,893,263...52,293,000
Q
Hpcl2
Hepatic cholesterol level QTL 2
IDA
RGD
PMID:18071061
RGD:1643359
NCBI chr10:45,529,164...96,099,749
Q
Hcuc1
Hepatic copper content QTL 1
IDA
3.0
RGD
PMID:11741328
RGD:619607
Q
Hcuc2
Hepatic copper content QTL 2
IDA
2.8
RGD
PMID:11741328
RGD:619607
Q
Hcuc3
Hepatic copper content QTL 3
IDA
3.87
RGD
PMID:12094018
RGD:629572
NCBI chr 2:212,145,502...231,732,847
Q
Hcuc4
Hepatic copper content QTL 4
IDA
4.15
RGD
PMID:12094018
RGD:629572
NCBI chr10:67,439,473...73,950,209
Q
Ginf2
Gastrointestinal inflammation QTL 2
IDA
0.005
3.21
RGD
PMID:19526527
RGD:2316974
NCBI chr 8:12,964,165...57,964,165
Q
Ginf3
Gastrointestinal inflammation QTL 3
IDA
0.005
2.89
RGD
PMID:19526527
RGD:2316974
NCBI chr17:54,829,503...93,515,804
Q
Hcar1
Hepatocarcinoma resistance QTL 1
IDA
1.0E-4
3.4
RGD
PMID:10493520
RGD:619598
NCBI chr10:6,661,118...35,509,383
Q
Hcar10
Hepatocarcinoma resistance QTL 10
IDA
2.9
RGD
PMID:12154055
RGD:629566
NCBI chr 8:49,610,204...68,373,388
Q
Hcar11
Hepatocarcinoma resistance QTL 11
IDA
4.4
RGD
PMID:12154055
RGD:629566
NCBI chr 6:46,050,607...116,278,722
Q
Hcar12
Hepatocarcinoma resistance QTL 12
IDA
2.6
RGD
PMID:12154055
RGD:629566
NCBI chr 3:49,872,657...138,829,559
Q
Hcar13
Hepatocarcinoma resistance QTL 13
IDA
4.3
RGD
PMID:15185337
RGD:737884
NCBI chr 4:1...33,538,816
Q
Hcar14
Hepatocarcinoma resistance QTL 14
IDA
4.3
RGD
PMID:15185337
RGD:737884
NCBI chr18:57,825,243...85,493,247
Q
Hcar15
Hepatocarcinoma resistance QTL 15
IDA
0.05
RGD
PMID:15771619
RGD:1358145
NCBI chr 1:162,548,015...270,518,180
Q
Hcar2
Hepatocarcinoma resistance QTL 2
IDA
3.0E-4
3.1
RGD
PMID:10493520
RGD:619598
NCBI chr 4:84,349,032...129,349,032
Q
Hcar3
Hepatocarcinoma resistance QTL 3
IDA
5.0E-4
2.9
RGD
PMID:10493520
RGD:619598
NCBI chr 8:62,982,864...107,982,864
Q
Hcar4
Hepatocarcinoma resistance QTL 4
IDA
4.6
RGD
PMID:10850431
RGD:619609
NCBI chr 1:202,851,915...223,964,440
Q
Hcar5
Hepatocarcinoma resistance QTL 5
IDA
8.0
RGD
PMID:10850431
RGD:619609
NCBI chr 1:223,964,326...236,074,012
Q
Hcar6
Hepatocarcinoma resistance QTL 6
IDA
RGD
PMID:10850431
RGD:619609
Q
Hcar7
Hepatocarcinoma resistance QTL 7
IDA
7.8
RGD
PMID:10850431
RGD:619609
NCBI chr 4:61,041,057...94,638,356
Q
Hcar8
Hepatocarcinoma resistance QTL 8
IDA
5.8
RGD
PMID:10850431
RGD:619609
NCBI chr 4:124,700,988...169,700,988
Q
Hcar9
Hepatocarcinoma resistance QTL 9
IDA
3.7
RGD
PMID:12154055
RGD:629566
NCBI chr 4:106,848,959...168,870,974
Q
Hcas1
Hepatocarcinoma susceptibility QTL 1
IDA
0.001
3.9
RGD
PMID:10493520
RGD:619598
NCBI chr 7:93,302,009...131,686,183
Q
Hcas2
Hepatocarcinoma susceptibility QTL 2
IDA
1.0E-4
3.0
RGD
PMID:10493520
RGD:619598
NCBI chr 1:7,746,118...52,746,118
Q
Hcas3
Hepatocarcinoma susceptibility QTL 3
IDA
4.9
RGD
PMID:12154055
RGD:629566
NCBI chr 1:153,679,879...232,414,077
Q
Hcas4
Hepatocarcinoma susceptibility QTL 4
IDA
4.43
RGD
PMID:12154055
RGD:629566
NCBI chr16:4,234,212...53,708,481
Q
Hcas5
Hepatocarcinoma susceptibility QTL 5
IDA
3.12
RGD
PMID:15185337
RGD:737884
NCBI chr 1:185,857,683...270,518,180
Q
Hcas6
Hepatocarcinoma susceptibility QTL 6
IDA
2.93
RGD
PMID:15185337
RGD:737884
NCBI chr14:39,411,170...87,582,095
Q
Hcas7
Hepatocarcinoma susceptibility QTL 7
IDA
2.91
RGD
PMID:15185337
RGD:737884
NCBI chr15:2,315,759...53,331,089
Q
Hcas8
Hepatocarcinoma susceptibility QTL 8
IDA
RGD
PMID:17079458
RGD:1599590
NCBI chr16:16,278,184...27,244,292
Q
Lnnr1
Liver neoplastic nodule remodeling QTL 1
IDA
0.001
3.85
RGD
PMID:12672032
RGD:629574
NCBI chr 7:36,178,764...81,178,764
Q
Lnnr2
Liver neoplastic nodule remodeling QTL 2
IDA
5.0E-4
2.9
RGD
PMID:12672032
RGD:629574
NCBI chr 1:243,953,669...270,518,180
Q
Lnnr3
Liver neoplastic nodule remodeling QTL 3
IDA
2.94
RGD
PMID:15185337
RGD:737884
NCBI chr 2:1...42,977,529
Q
Lnnr4
Liver neoplastic nodule remodeling QTL 4
IDA
3.64
RGD
PMID:15185337
RGD:737884
NCBI chr13:1...34,785,618
Q
Lnnr5
Liver neoplastic nodule remodeling QTL 5
IDA
3.29
RGD
PMID:15185337
RGD:737884
NCBI chr13:62,424,592...88,113,509
Q
Lnnr6
Liver neoplastic nodule remodeling QTL 6
IDA
3.3
RGD
PMID:15185337
RGD:737884
NCBI chr13:65,613,454...109,350,286
Q
Livw1
Liver weight QTL 1
IDA
3.0E-4
3.6
RGD
PMID:15728334
RGD:1580752
NCBI chr 1:170,078,537...182,384,005
Q
Livw2
Liver weight QTL 2
IDA
4.0E-4
3.5
RGD
PMID:15728334
RGD:1580752
NCBI chr 5:104,018,576...124,314,782
Q
Livw3
Liver weight QTL 3
IDA
0.01
2.43
RGD
PMID:19526527
RGD:2316974
NCBI chr 8:12,964,165...57,964,165
Q
Livw4
Liver weight QTL 4
IDA
3.8
RGD
PMID:25296178
RGD:10402111
NCBI chr 7:72,725,037...117,725,037
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all